Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.

Hanna HuebnerPeter A FaschingWalter GumbrechtSebastian JudClaudia RauhMark MatzasPeter PaulickaKatja FriedrichMichael P LuxBernhard VolzPaul GassLothar HäberleFranziska Meier-StiegenAndreas HartkopfHans NeubauerKatrin AlmstedtMatthias W BeckmannTanja N FehmMatthias Ruebner

Published in: BMC cancer (2018)

The newly established EpCAM independently filtration-based system is a suitable method to determine CTC counts for MBC patients. Our study confirms CTCs as being strong predictors of prognosis in our population of MBC patients.

Keyphrases

circulating tumor cells
end stage renal disease
ejection fraction
prognostic factors
small cell lung cancer
peritoneal dialysis
squamous cell carcinoma
patient reported outcomes
peripheral blood
cell adhesion
clinical evaluation